{
    "nctId": "NCT00763100",
    "briefTitle": "Efficacy of Tomosynthesis in the BIRADS 3 Population",
    "officialTitle": "The Efficacy of Tomosynthesis in the BIRADS 3 Population Including Surveillance of Patients in the Treatment or Post-Treatment for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 690,
    "primaryOutcomeMeasure": "to see if Breast Tomosynthesis, a three-dimensional (3D) imaging study is more accurate than standard mammography (a two-dimensional (2D) study).",
    "eligibilityCriteria": "Inclusion Criteria:\n\nGROUP 1\n\n* female of any race and ethnicity\n* 35 years or older\n* after routine and diagnostic imaging, subject is categorized as a BI-RADS 3 and will undergo study imaging within 30 days of routine or diagnostic imaging.\n* subject is returning for surveillance imaging after a categorization of a BI-RADS 3 and will undergo study imaging within 30 days of surveillance imaging GROUP 2\n* female of any race and ethnicity\n* 26 years or older\n* subject has completed cancer treatment and is currently categorized as a BI-RADS 3 for surveillance imaging\n* subject will undergo study imaging within 30 days of surveillance imaging GROUP 3\n* female of any race and ethnicity\n* 26 years or older\n* subject is currently undergoing cancer treatment and is currently categorized as a BI-RADS 3 for surveillance imaging OR\n* subject will undergo study imaging within 30 days of surveillance imaging\n\nExclusion Criteria:\n\n* GROUP 1, 2 and 3\n* subjects unable or unwilling to participate\n* subjects who are unable or unwilling to tolerate compression\n* subjects who are pregnant or who think they may be pregnant\n* subjects who are breastfeeding",
    "sex": "FEMALE",
    "minimumAge": "26 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}